Showing results (71-80 of 379) with videos related to
Sort By:
Pageof 38
Progress in Clinical and Biological Research|January 1, 1987
Antigen-specific cultured T cells can mediate tumor therapy and provide long-term immunologic memory in vivoM A Cheever, J P Klarnet, D J Peace, et al.Cancer Research|October 1, 1990
Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cellsD E Kern, J P Klarnet, M A Cheever, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1994
Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivoW Chen, E Schweins, X Chen, et al.Immunobiology|September 1, 1986
Potential uses of interleukin 2 in cancer therapyM A Cheever, J A Thompson, D J Peace, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1985
Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growthM A Cheever, J A Thompson, D E Kern, et al.The Journal of Experimental Medicine|May 1, 1986
Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cellsM A Cheever, D B Thompson, J P Klarnet, et al.Journal of Biological Response Modifiers|October 1, 1984
Interleukin-2 administered in vivo induces the growth and augments the function of cultured T cells in vivoM A Cheever, J A Thompson, D E Kern, et al.Spine|October 1, 1984
A preoperative chymopapain sensitivity test for chemonucleolysis candidatesY G Tsay, R Jones, E Calenoff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: high complete response rate in a phase I-II study of doxorubicin-treated patientsG K Ellis, J R Gralow, H I Pierce, et al.Blood|September 9, 1999
CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cellsA Cignetti, E Bryant, B Allione, et al.Pageof 38